In:
Global Pharmaceutical Sciences Review, Humanity Only - HO, Vol. VIII, No. I ( 2023-3-30), p. 10-15
Abstract:
This study evaluates the efficacy of pan retinal and targeted retinal photocoagulation (PRP and TRP) for the treatment of proliferative diabetic retinopathy (PDR). A retrospective review of medical records was conducted of patients with PDR who had undergone PRP or TRP as primary treatment at a tertiary care center. Outcome measures included visual acuity, intraocular pressure, and retinal appearance. Results showed that PRP and TRP were both effective in reducing intraocular pressure and improving visual acuity, with no significant difference between the two. However, PRP was associated with a higher rate of retinal detachment and greater risk of recurrence of PDR. Based on the results, PRP and TRP are both effective treatments for PDR, but PRP may be associated with increased risk of complications.
Type of Medium:
Online Resource
ISSN:
2788-5445
,
2788-5569
DOI:
10.31703/gpsr.2023(VIII-I)
DOI:
10.31703/gpsr.2023(VIII-I).02
Language:
English
Publisher:
Humanity Only - HO
Publication Date:
2023